Arvind Sood | VP, IR |
Bob Bradway | Chairman and CEO |
Peter Griffith | CFO |
Murdo Gordon | EVP, Global Commercial Operations |
David Reese | EVP, Research and Development |
Michael Yee | Jefferies |
Jay Olson | Oppenheimer |
Goeff Meacham | Bank of America |
Salveen Richter | Goldman Sachs |
Matthew Harrison | Morgan Stanley |
Yaron Werber | Cowen & Company |
Umer Raffat | Evercore ISI |
Carter Gould | Barclays |
Robyn Karnauskas | Truist |
Mohit Bansal | Wells Fargo |
Dane Leone | Raymond James |
Evan Seigerman | BMO Capital Markets |
Gavin Scott | JPMorgan |
Colin Bristow | UBS |
My name is RJ, and I will be your conference facilitator today for Amgen's First Quarter 2022 Financial Results Conference Call. All lines have been placed on mute to prevent any background nose. There will be a question-and-answer session at the conclusion of the last speaker's prepared remarks. In order to ensure that everyone has a chance to participate, we would like to request that you limit yourself to asking one question during the Q&A session. [Operator Instructions] I would now like to introduce Arvind Sood, Vice President of Investor Relations.